Work

Phase I Evaluation of Crisnatol (BWA770U Mesylate) on a Monthly Extended Infusion Schedule

Year: 1991

Type: article

Study design: Clinical Trial

Source: Selective Cancer Therapeutics

DOI: 10.1089/sct.1991.7.85

Authors: PATRICK W. COBB, KATHLEEN A. HAVLIN, JOHN G. KUHN, JOHN B. CRAIG, GLENN S. HARMAN, J. SCOTT LUTHER, JUDY N. TURNER, GEOFFREY R. WEISS, DENNIS A. TWEEDY, JIM KOELLER, RICHARD L. TUTTLE, V. SOL LUCAS, WILLIAM WARGIN, JOHN K. WHISNANT, DANIEL D. VON HOFF

Institution: The University of Texas at San Antonio Health Science Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Center for Research Resources

Awards: GENERAL CLINICAL RESEARCH CENTER, G737160722

OpenAlex ID: W2174162872

FWCI:

Cites: 2

Cited by: 2

Related to: 10